UBS Group AG - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 14 filers reported holding IBERE PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$5,982
-0.3%
6000.0%0.00%–
Q3 2022$6,000
+100.0%
600
+76.5%
0.00%–
Q2 2022$3,0000.0%3400.0%0.00%–
Q1 2022$3,0000.0%3400.0%0.00%–
Q4 2021$3,000
-62.5%
340
-59.5%
0.00%–
Q1 2021$8,000–840–0.00%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q3 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders